Corvus Pharmaceuticals, Inc. Quarterly Operating Lease, Payments in USD from Q1 2018 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Corvus Pharmaceuticals, Inc. quarterly/annual Operating Lease, Payments history and growth rate from Q1 2018 to Q2 2024.
  • Corvus Pharmaceuticals, Inc. Operating Lease, Payments for the quarter ending June 30, 2024 was $473K, a 2.83% increase year-over-year.
  • Corvus Pharmaceuticals, Inc. Operating Lease, Payments for the twelve months ending June 30, 2024 was $1.87M, a 6.75% increase year-over-year.
  • Corvus Pharmaceuticals, Inc. annual Operating Lease, Payments for 2023 was $1.84M, a 8.5% increase from 2022.
  • Corvus Pharmaceuticals, Inc. annual Operating Lease, Payments for 2022 was $1.7M, a 3.04% increase from 2021.
  • Corvus Pharmaceuticals, Inc. annual Operating Lease, Payments for 2021 was $1.65M, a 9.23% increase from 2020.
Operating Lease, Payments, Trailing 12 Months (USD)
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $1.87M $473K +$13K +2.83% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-06
Q1 2024 $1.85M $473K +$14K +3.05% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $1.84M $461K +$65K +16.4% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-19
Q3 2023 $1.77M $459K +$26K +6.01% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-07
Q2 2023 $1.75M $460K +$27K +6.24% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-06
Q1 2023 $1.72M $459K +$26K +6.01% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 $1.7M $396K -$10K -2.46% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-19
Q3 2022 $1.71M $433K +$20K +4.84% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 $1.69M $433K +$20K +4.84% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 $1.67M $433K +$20K +4.84% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-08
Q4 2021 $1.65M $406K +$31K +8.27% Oct 1, 2021 Dec 31, 2021 10-K 2024-03-19
Q3 2021 $1.61M $413K +$36K +9.55% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 $1.58M $413K +$36K +9.55% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
Q1 2021 $1.54M $413K +$36K +9.55% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 $1.51M $375K +$18K +5.04% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-28
Q3 2020 $1.49M $377K +$14K +3.86% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-01
Q2 2020 $1.47M $377K +$7K +1.89% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-02
Q1 2020 $1.47M $377K +$18K +5.01% Jan 1, 2020 Mar 31, 2020 10-Q 2021-04-29
Q4 2019 $1.45M $357K +$10K +2.88% Oct 1, 2019 Dec 31, 2019 10-K 2022-03-10
Q3 2019 $1.44M $363K +$20K +5.83% Jul 1, 2019 Sep 30, 2019 10-Q 2020-10-29
Q2 2019 $1.42M $370K +$27K +7.87% Apr 1, 2019 Jun 30, 2019 10-Q 2020-07-30
Q1 2019 $1.39M $359K +$3K +0.84% Jan 1, 2019 Mar 31, 2019 10-Q 2020-04-30
Q4 2018 $1.39M $347K Oct 1, 2018 Dec 31, 2018 10-K 2021-03-25
Q3 2018 $343K Jul 1, 2018 Sep 30, 2018 10-Q 2019-10-30
Q2 2018 $343K Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-01
Q1 2018 $356K Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.